Annual Information Update (2040G)
May 09 2011 - 7:01AM
UK Regulatory
TIDMHIK
RNS Number : 2040G
Hikma Pharmaceuticals Plc
09 May 2011
Annual Information Update
LONDON, 9 May 2011. In accordance with Prospectus Rule 5.2,
Hikma Pharmaceuticals PLC ("Hikma" or "the Company") (LSE: HIK)
sets out below a summary of the information which has been
published or made available to the public over the period. The
information referred to in this Update was up to date at the time
the information was published, but some information may now be out
of date.
Stock Exchange Announcements
Announcements made by the Company via RNS, a Regulatory
Information Service, may be viewed and downloaded from the
Company's market news section on the London Stock Exchange website
at
(http://www.londonstockexchange.com/prices-and-news/stocks/stocks-and-pr
ices.htm) or from the press releases page on the Company's website
at (http://www.hikma.com/investorrelations/rns/). The Stock
Exchange announcements made during the period were:
Date of Announcement Headline of Announcement
--------------------- ----------------------------------------
03/05/2011 Statement re Completion of Acquisition
--------------------- ----------------------------------------
15/04/2011 Agreement with Unimark Remedies Limited
--------------------- ----------------------------------------
13/04/2011 Director/PDMR Shareholding
--------------------- ----------------------------------------
11/04/2011 Total Voting Rights
--------------------- ----------------------------------------
11/04/2011 Blocklisting Interim Review
--------------------- ----------------------------------------
04/04/2011 Director/PDMR Shareholding
--------------------- ----------------------------------------
18/03/2011 Director/PDMR Shareholding
--------------------- ----------------------------------------
16/03/2011 Preliminary Results
--------------------- ----------------------------------------
02/03/2011 Total Voting Rights
--------------------- ----------------------------------------
08/02/2011 Total Voting Rights
--------------------- ----------------------------------------
03/02/2011 Holding(s) in Company
--------------------- ----------------------------------------
24/01/2011 Appointments
--------------------- ----------------------------------------
12/01/2011 Total Voting Rights
--------------------- ----------------------------------------
12/01/2011 Director/PDMR Shareholding
--------------------- ----------------------------------------
10/01/2011 Director/PDMR Shareholding
--------------------- ----------------------------------------
10/01/2011 Director/PDMR Shareholding
--------------------- ----------------------------------------
05/01/2011 Total Voting Rights
--------------------- ----------------------------------------
16/12/2010 Director/PDMR Shareholding
--------------------- ----------------------------------------
06/12/2010 Director/PDMR Shareholding
--------------------- ----------------------------------------
01/12/2010 Director/PDMR Shareholding
--------------------- ----------------------------------------
12/11/2010 Interim Management Statement
--------------------- ----------------------------------------
09/11/2010 Director/PDMR Shareholding
--------------------- ----------------------------------------
05/11/2010 Total Voting Rights
--------------------- ----------------------------------------
04/11/2010 Director/PDMR Shareholding
--------------------- ----------------------------------------
02/11/2010 Director/PDMR Shareholding
--------------------- ----------------------------------------
29/10/2010 Acquisition
--------------------- ----------------------------------------
18/10/2010 Product Update
--------------------- ----------------------------------------
15/10/2010 Block Listing for Share Schemes
--------------------- ----------------------------------------
04/10/2010 Total Voting Rights
--------------------- ----------------------------------------
04/10/2010 Blocklisting Interim Review
--------------------- ----------------------------------------
01/10/2010 Company Update
--------------------- ----------------------------------------
06/09/2010 Total Voting Rights
--------------------- ----------------------------------------
26/08/2010 Interim Results
--------------------- ----------------------------------------
04/08/2010 Voting Rights and Capital
--------------------- ----------------------------------------
02/08/2010 Annual Information Update
--------------------- ----------------------------------------
All of the above announcements were also made by the Company via
the NasdaqDubai stock exchange CANDI system. These announcements
may be viewed and downloaded from the NasdaqDubai website
(www.candi.nasdaq.com).
Documents filed with the Financial Services Authority
The Company has filed the following documents with the Financial
Services Authority ("FSA") visa the National Storage Mechanism over
the previous 12 months. These documents are available at
http://www.hemscott.com/nsm.do or at the Company's registered
office.
Date Document
-------------- ----------------------------------------
6 April 2011 Annual Report and Accounts 2010
-------------- ----------------------------------------
6 April 2011 Notice of 2011 Annual General Meeting
-------------- ----------------------------------------
14 April 2011 Proxy forms for the 2011 Annual General
Meeting
-------------- ----------------------------------------
Documents filed with Companies House
The Company submitted filings to the Registrar of Companies in
England and Wales as detailed in the table below.
Date Filed Form Description
----------- ----- -------------------------------------------
08/02/2011 SH01 31/01/11 Statement of Capital GBP 19356098
----------- ----- -------------------------------------------
14/01/2011 SH01 31/12/10 Statement of Capital GBP 19351698
----------- ----- -------------------------------------------
05/01/2011 SH01 30/11/10 Statement of Capital GBP 19344848
----------- ----- -------------------------------------------
11/11/2010 SH01 31/10/10 Statement of Capital GBP 19340139
----------- ----- -------------------------------------------
18/10/2010 SH01 30/09/10 Statement of Capital GBP 19338739
----------- ----- -------------------------------------------
09/09/2010 AR01 08/09/10 Full List
----------- ----- -------------------------------------------
02/09/2010 CH01 Director's Change of Particulars / Samih
Darwazah / 01/09/2010
----------- ----- -------------------------------------------
02/09/2010 CH01 Director's Change of Particulars / Ali
Al Husry / 01/09/2010
----------- ----- -------------------------------------------
02/09/2010 CH01 Director's Change of Particulars / Mazen
Samih Darwazeh / 01/09/2010
----------- ----- -------------------------------------------
02/09/2010 CH01 Director's Change of Particulars / Ronald
Lane Goode / 01/09/2010
----------- ----- -------------------------------------------
01/09/2010 CH01 Director's Change of Particulars / Michael
Richard Dwyer Ashton / 01/09/2010
----------- ----- -------------------------------------------
01/09/2010 CH01 Director's Change of Particulars / Said
Samih Darwazah / 01/09/2010
----------- ----- -------------------------------------------
01/09/2010 CH01 Director's Change of Particulars / Breffni
John Byrne / 01/09/2010
----------- ----- -------------------------------------------
01/09/2010 CH01 Director's Change of Particulars / Sir
David Rowe Ham / 01/09/2010
----------- ----- -------------------------------------------
01/09/2010 CH03 Secretary's Change of Particulars / Henry
James Knowles / 01/09/2010
----------- ----- -------------------------------------------
23/08/2010 SH01 30/06/10 Statement of Capital GBP 19336649
----------- ----- -------------------------------------------
Copies of all these documents may be obtained from Companies
House, Crown Way, Maindy, Cardiff CF14 3UZ or, if you are a
registered user, they may be viewed and downloaded using Companies
House Direct at www.direct.companieshouse.gov.uk.
Further Information
Further information about Hikma Pharmaceuticals PLC can be found
at our website www.hikma.com. Copies of all documents can be
obtained from the Company at the registered office which is located
at 13 Hanover Square, London W1S 1HW.
Henry Knowles Company Secretary 9 May 2011
- ENDS -
Enquiries:
Hikma Pharmaceuticals PLC
Henry Knowles
Company Secretary +44 20 7399 2670
Susan Ringdal
Investor Relations Director +44 20 7399 2670
Financial Dynamics
Ben Atwell/ Julia Phillips +44 20 7269 7242
Jonathan Birt/ Matthew Cole
About Hikma
Hikma Pharmaceuticals PLC is a fast growing multinational group
focused on developing, manufacturing and marketing a broad range of
both branded and non-branded generic and in-licensed pharmaceutical
products. Hikma's operations are conducted through three
businesses: "Branded", "Injectables" and "Generics". Hikma's
operations are based principally in the Middle East and North
Africa ("MENA") region, where it is a market leader and sells
across 17 countries, the United States and Europe. In 2010, the
Group achieved revenues of $731 million (2009 $637 million) and
profit attributable to shareholders was $99 million (2009 $78
million). For news and other information, please visit
www.hikma.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
AIUBKLFBFEFEBBK
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024
